Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05104515
What this trial is testing

First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine

Who this might be right for
Prostate CancerNon Small Cell Lung CancerOvarian Cancer
Oxford Vacmedix UK Ltd. 36
Large-scale testing (Phase 3)Ended earlyNCT02134015
What this trial is testing

Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
Daiichi Sankyo 145
Testing effectiveness (Phase 2)Study completedNCT02573506
What this trial is testing

Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 99
Not applicableActive Not RecruitingNCT06337552
What this trial is testing

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

Who this might be right for
Rectal CancerNon-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 39
Testing effectiveness (Phase 2)UnknownNCT05847764
What this trial is testing

Disitamab Vedotin Combined Therapy for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations

Who this might be right for
Non Small Cell Lung CancerERBB2 Mutation-Related TumorsRC48+1 more
Sun Yat-sen University 95
Testing effectiveness (Phase 2)Ended earlyNCT02157116
What this trial is testing

Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Duke University 13
Large-scale testing (Phase 3)Active Not RecruitingNCT06711900
What this trial is testing

SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 432
Testing effectiveness (Phase 2)Looking for participantsNCT07468071
What this trial is testing

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Who this might be right for
Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung CancerAdvanced Solid Tumors Harboring the KRAS G12C Mutation
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT05933044
What this trial is testing

RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 662
Not applicableLooking for participantsNCT07288632
What this trial is testing

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Who this might be right for
Venous Thromboembolism (VTE)NSCLC (Advanced Non-small Cell Lung Cancer)
University Of Perugia 500
Not applicableEnded earlyNCT02483416
What this trial is testing

Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)UnknownNCT04182698
What this trial is testing

Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC

Who this might be right for
Patients With Non-small Cell Lung Cancer
Second Affiliated Hospital of Xi'an Jiaotong University 90
Early research (Phase 1)Active Not RecruitingNCT04603287
What this trial is testing

SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors

Who this might be right for
Locally Advanced or Metastatic Epithelial Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT06589778
What this trial is testing

SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 124
Not applicableStudy completedNCT05291780
What this trial is testing

Stereotactic Ablative Radiotherapy in Locally Advanced Non Small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Small Cell Carcinoma
Radiotherapy Oncology Centre "Santa Maria" Hospital 80
Early research (Phase 1)Looking for participantsNCT06521554
What this trial is testing

NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Nuvalent Inc. 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07739186
What this trial is testing

A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 120
Early research (Phase 1)Study completedNCT04895579
What this trial is testing

Lung Cancer With Copanlisib and Durvalumab

Who this might be right for
Non Small Cell Lung Cancer
Zhonglin Hao 11
Testing effectiveness (Phase 2)Looking for participantsNCT06574347
What this trial is testing

Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.

Who this might be right for
Non-Small-Cell Lung Cancer
Avistone Biotechnology Co., Ltd. 120
Early research (Phase 1)Looking for participantsNCT07140016
What this trial is testing

Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Anaplastic Lymphoma Kinase (ALK) Positive
Astellas Pharma Global Development, Inc. 40
Next Page